Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-0886-2026

MEDLINE PERFUSION SYRINGE, REF: DYNJ39223C Recall

MEDLINE PERFUSION SYRINGE, REF: DYNJ39223C

FDA recall Class II

Ongoing

FDA lists this Class II recall for MEDLINE PERFUSION SYRINGE, REF: DYNJ39223C. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-0886-2026
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Oct 27, 2025
FDA report date
Dec 17, 2025
Quantity in commerce
15 units
Distribution
See key details
FDA cause
Under Investigation by firm

What is being recalled?

MEDLINE PERFUSION SYRINGE, REF: DYNJ39223C

Affected model & UDI checker

Search the exact identifiers published for Z-0886-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
DYNJ39223CMEDLINE PERFUSION SYRINGE, REF: DYNJ39223CCheck source noticeNot specified
Not specifiedMEDLINE PERFUSION SYRINGE, REF: DYNJ39223CCheck source notice10193489621532
Not specifiedMEDLINE PERFUSION SYRINGE, REF: DYNJ39223CCheck source notice40193489621533
FDA code information

UDI/DI 10193489621532 (each) 40193489621533 (case), Lot Number 25FMJ081

View the original FDA recall notice

Why was this product recalled?

Medline Industries, LP is issuing a recall for specific item(s) and lot(s) of Medline Kits containing BD Luer Tip Caps. BD has issued a recall of their Luer Tip Caps after confirming through internal testing that certain BD Luer Tip Cap trays failed routine biocompatibility testing. Although the tip cap covers a small surface area of the syringe and does not come in direct contact with patients, there is the potential that the failure of a biocompatibility test may have varying consequences ranging from no harm or clinical impact to potential for sensitization, irritation, pyrogenicity, acute systemic toxicity or hemolysis depending on the nature and duration of contact with the syringe.

These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.

What actions did Medline Industries, LP take?

Medline Industries issued an URGENT MEDICAL DEVICE RECALL to its consignee on 10/27/2025 via email. The notice explained the issue, potential risk, and requested the affected product be quarantined. Once the firm receives the response form, Medline will provide over-labels which are to be placed on kits that contain the recalled component and will state the affected component shall be removed and discarded from further use. Distributors and those further distributing the affected product are directed to notify those to whom the product was transferred or distributed of the recall. For questions, contact the Recall Department at 866-359-1704 or recalls@medline.com.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology